Cognitive impairment six months after ischaemic stroke: A profile from the ASPIRE-S study

BMC Neurology

Volumn 15, Issue 1, 2015, Pages

  Mellon, Lisa ^a   Brewer, Linda ^a   Hall, Patricia ^a   Horgan, Frances ^a   Williams, David ^a   Hickey, Anne ^a   McGee, Hannah ^a   Shelley, Emer ^a   Kelly, Peter ^b   Dolan, Eamon ^c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c Stroke and Hypertension Unit   (Ireland)

Author keywords

Cognition; Cognitive impairment; Secondary prevention; Stroke rehabilitation

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT;

AGED; ANAMNESIS; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG USE; FEMALE; FUNCTIONAL STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SEX DIFFERENCE; SURVIVOR; TEACHING HOSPITAL; TRANSIENT ISCHEMIC ATTACK; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; PSYCHOLOGY; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SECONDARY PREVENTION; STROKE; SURVIVORS;

EID: 84928728979     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-015-0288-2     Document Type: Article

References (51)

1. Mendis S. Stroke disability and rehabilitation of stroke: World Health Organization perspective. Intern J Stroke. 2013;8(1):3-4
2. Royal College of Physicians. National Sentinel Stroke Clinical Audit 2010. Dublin, Ireland: Intercollegiate Stroke Working Party; 2011
3. Feigin VL, Barker-Collo S, Parag V, Senior H, Lawes CM, Ratnasabapathy Y, et al. Auckland Stroke Outcomes Study. Part 1: Gender, stroke types, ethnicity, and functional outcomes 5 years poststroke. Neurology. 2010;75 (18):1597-607
4. Van Peppen RP, Kwakkel G, Wood-Dauphinee S, Hendriks HJ, Van der Wees PJ, Dekker J. The impact of physical therapy on functional outcomes after stroke: what's the evidence? Clin Rehabil. 2004;18(8):833-62
5. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and metaanalysis. Lancet Neurol. 2009;8(11):1006-18
6. Salvadori E, Pasi M, Poggesi A, Chiti G, Inzitari D, Pantoni L. Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J Neurol. 2013;260(9):2220-7
7. Douiri A, Rudd AG, Wolfe CD. Prevalence of poststroke cognitive impairment: South London Stroke Register 1995-2010. Stroke. 2013;44 (1):138-45
8. British Psychological Society. Briefing paper 19: psychological services for stroke survivors and their families. Leicester: British Psychological Society; 2002
9. Iemolo F, Duro G, Rizzo C, Castiglia L, Hachinski V, Caruso C. Pathophysiology of vascular dementia. Immun Ageing. 2009;6:13
10. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163(9):1069-75
11. Douiri A, McKevitt C, Emmett ES, Rudd AG, Wolfe CD. Long-term effects of secondary prevention on cognitive function in stroke patients. Circulation. 2013;128(12):1341-8
12. Kelly PJ, Crispino G, Sheehan O, Kelly L, Marnane M, Merwick A, et al. Incidence, event rates, and early outcome of stroke in Dublin, Ireland: the North Dublin population stroke study. Stroke. 2012;43(8):2042-7
13. Hannon N, Callaly EL, Moore A, Ni Chroinin D, Sheehan O, Marnane M, et al. Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study. Stroke. 2011;42(9):2503-8
14. Ni Chroinin D, Callaly EL, Duggan J, Merwick A, Hannon N, Sheehan O, et al. Association between acute statin therapy, survival, and improved functional outcomes after ischemic stroke. The North Dublin Population Stroke Study. Stroke. 2011;42:1021-9
15. World Health Organisation. International classification of impairments, disabilites and handicaps: a manual of classification relating to the consequences of diseases. Geneva, Switzerland: World Health Organisation; 1980
16. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke-background and study protocol. Scandinavian Stroke Study Group. Stroke. 1985;16(5):885-90
17. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337(8756):1521-6
18. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41
19. Rankin J. Cerebral vascular accidents in patients over the age of 60. II Prognosis. Scott Med J. 1957;2(5):200-15
20. Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in contemporary stroke trials. Int J Stroke. 2009;4(3):200-5
21. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-9
22. Lees R, Selvarajah J, Fenton C, Pendlebury ST, Langhorne P, Stott DJ, et al. Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke. Stroke. 2014;45(10):3008-18
23. Cumming TB, Churilov L, Linden T, Bernhardt J. Montreal Cognitive Assessment and Mini-Mental State Examination are both valid cognitive tools in stroke. Acta Neurol Scand. 2013;128(2):122-9
24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70
25. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77
26. Aben I, Verhey F, Lousberg R, Lodder J, Honig A. Validity of the beck depression Inventory, hospital anxiety and depression scale, SCL-90 and hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics. 2002;43(5):386-93
27. Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691-9
28. Williams LS, Weinberger M, Harris LE, Clark DO, Biller J. Development of a stroke-specific quality of life scale. Stroke. 1999;30(7):1362-9
29. Jl S, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepalveda MV, Pan W, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480-8
30. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66(3):411-21
31. Green SB. How many subjects does it take to do a regression analysis. Multivar Beh Res. 1991;26(3):499-510
32. Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2012;3:2012
33. Heuschmann PU, Kircher J, Nowe T, Dittrich R, Reiner Z, Cifkova R, et al. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey. Eur J Prev Cardiol. 2014 Aug 19. [Epub ahead of print]
34. Patel M, Coshall C, Rudd AG, Wolfe C. Natural history of cognitive impairment after stroke and factors associated with its recovery. Clin Rehabil. 2003;17(2):158-66
35. Nys GM, van Zandvoort MJ, de Kort PL, Jansen BP, de Haan EH, Kappelle LJ. Cognitive disorders in acute stroke: prevalence and clinical determinants. Cerebrovasc Dis. 2007;23(5-6):408-16
36. Nair RD, Lincoln NB. Cognitive rehabilitation for memory deficits following stroke. Cochrane Database Syst Rev. 2007;3:CD002293
37. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord. 2009;28(1):75-80
38. Campbell NL, Boustani MA, Skopelja EN, Gao S, Unverzagt FW, Murray MD. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother. 2012;10(3):165-77
39. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345-51
40. Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987;107(2):169-73
41. May C, Montori VM, Mair FS. We need minimally disruptive medicine 2009. BMJ. 2009-08-11 23:06:19
42. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-35
43. National Institute for Health and Clinical Excellence. Stroke Quality Standard. London: National Institute for Health and Clinical Excellence; 2010
44. Lees RA, Broomfield NM, Quinn TJ. Questionnaire assessment of usual practice in mood and cognitive assessment in Scottish stroke units. Disabil Rehabil. 2014;36(4):339-43
45. Dong Y, Lee WY, Basri NA, Collinson SL, Merchant RA, Venketasubramanian N, et al. The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatr. 2012;24(11):1749-55
46. Waldron-Perrine B, Axelrod BN. Determining an appropriate cutting score for indication of impairment on the Montreal Cognitive Assessment. Int J Geriatr Psychiatry. 2012;27(11):1189-94
47. Coen RF, Cahill R, Lawlor BA. Things to watch out for when using the Montreal cognitive assessment (MoCA). Int J Geriatr Psychiatry. 2011;26(1):107-8
48. Hachinski V. The 2005 Thomas Willis Lecture: stroke and vascular cognitive impairment: a transdisciplinary, translational and transactional approach. Stroke. 2007;38(4):1396
49. Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr. 2004;16(3):275-93
50. van Rooij FG, Schaapsmeerders P, Maaijwee NA, van Duijnhoven DA, de Leeuw FE, Kessels RP, et al. Persistent cognitive impairment after transient ischemic attack. Stroke. 2014;45(8):2270-4
51. Pendlebury ST, Wadling S, Silver LE, Mehta Z, Rothwell PM. Transient cognitive impairment in TIA and minor stroke. Stroke. 2011;42(11):3116-21